Theratechnologies (TH) AGM 2025 summary

Opening remarks and agenda

• Meeting opened with introductions of CEO, Chair, CFO, and General Counsel, and outlined rules for conduct and voting.

• Meeting conducted in English due to significant U.S. shareholder presence; electronic voting procedures explained.

• Shareholders could submit questions throughout, with responses scheduled for the end of the meeting.

Board and executive committee updates

• Eight directors were nominated: Joseph Arena, Paul Lévesque, Andrew Molson, Dawn Svoronos, Elene T., Dale Weil, Jordan Zwick, and Frank Holler.

• All nominees confirmed willingness to serve; no other nominations received.

Overview of voting outcomes

• Over 52% of shares were represented; quorum confirmed.

• Directors elected with votes ranging from 77.98% to 84.03%.

• KPMG reappointed as auditors with 94.99% support.

• Omnibus long-term incentive compensation plan (Resolution 2025-1) approved with 69.58% support.

• All business matters passed as proposed; results to be published via press release and regulatory filings.